Oncoceutics Inc. and The University of Texas MD Anderson Cancer Center today announced the initiation of a strategic alliance and research collaboration agreement for the clinical development of ONC201, a novel anti-cancer drug.
from The Medical News http://ift.tt/1tEz2uw
from The Medical News http://ift.tt/1tEz2uw
No comments:
Post a Comment